Ultrasonographic Evaluation of Arteries of the Hand in Pediatric Patients
Launched by ANKARA UNIVERSITY · Apr 23, 2024
Trial Information
Current as of August 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to best measure two important arteries in the hand, called the ulnar and radial arteries, in children. The goal is to find the best way to determine their size using ultrasound, which is a safe imaging technique. This information could help doctors when they need to insert a small tube (called a cannula) into these arteries during certain surgeries.
To participate in this study, children aged from birth up to 10 years who are scheduled for elective surgeries may be eligible, provided they are in good health according to specific guidelines. Parents or guardians will need to give consent for their child to join the trial. Participants will undergo ultrasound measurements, which are painless and non-invasive. It's important to note that children with certain health conditions or issues at the cannulation site will not be included in the study. Overall, this trial aims to improve how doctors can safely access arteries in young patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • American Society of Anesthesiologists (ASA) physical status 1 or 2
- • Patients scheduled for elective surgical procedures
- • Informed consent must be obtained from both the patient and, if applicable, their parent or guardian.
- Exclusion Criteria:
- • Patients over 10 years of age
- • Patients with congenital anomalies or syndromic conditions
- • Abnormal Allen Test
- • Skin Erosion or infection at the cannulation site
- • Hematoma at the cannulation site
About Ankara University
Ankara University, a prominent institution in Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with various stakeholders to design and implement studies that address critical health challenges. Leveraging a diverse network of experienced researchers and state-of-the-art facilities, Ankara University aims to contribute significantly to the global medical community by generating valuable insights and fostering the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported